Cuprina Holdings (Cayman) Limited Announces Closing of Public Offering

Cuprina Holdings (Nasdaq: CUPR), a biomedical company focused on chronic wounds, infertility, medical waste recycling, and cosmeceuticals, closed its public offering of 4.32 million Class A Ordinary Shares at $1.15 per share, raising approximately $4.97 million in gross proceeds. The company plans to use net proceeds for R&D expansion, new market entry, brand building, and infrastructure investment. The offering follows FDA 510(k) clearance for MEDIFLY Maggots™ in June.